MAD Phase I Study to Investigate Contraloid Acetate
Conditions: Alzheimer Dementia; Alzheimer Disease Intervention: Drug: Contraloid Sponsors: Prof. Dr. Dieter Willbold; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; Medical University of Vienna; NeuroScios, Austria; Nuvisan, Germany; Fundación Teófilo Hernando, Spain; Alzheimer's Association Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alzheimer's | Austria Health | Brain | Dementia | Germany Health | Neurology | Nutrition | Research | Spain Health | Study